Posts Tagged ‘drug patent’

Patent Pending Drug for Artherosclerosis

       Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). Merck’s second generation niacin receptor agonist is a combatant to artherosclerosis.           Will the patented drug enter the market?      ... Read More

A Patent-Pending Patent Protector?

How are you imbuing authenticity within your product's concept? When an idea is innovative enough, being first is itself the strongest voice of authenticity.

Medical Patent in the Works for Cocaine Vaccination?

Dr. Tom Kosten, a professor of psychiatry at the Baylor College of Medicine, and his wife, neuroscientist and psychologist Dr. Therese Kosten are working on a medication to aid people in stopping cocaine addiction, according to a recent Newsweek article.